Evaluation of sub clinical target organ damage for risk assessment and treatment in the hypertensive patients: Left ventricular hypertrophy

Journal of the American Society of Nephrology

Volumn 17, Issue SUPPL. 2, 2006, Pages

  Agabiti Rosei, Enrico ^a   Muiesan, Maria Lorenza ^a   Salvetti, Massimo ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; COLLAGEN; CYTOKINE; NEUROHORMONE;

AUTONOMIC NERVOUS SYSTEM FUNCTION; BODY SIZE; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DIASTOLE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE CONTRACTILITY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RACE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; SEX DIFFERENCE; STROKE; SUDDEN DEATH; VASCULAR FIBROSIS; DRUG EFFECT; METHODOLOGY; PATHOLOGY; REVIEW; RISK FACTOR;

ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; PROGNOSIS; RENIN-ANGIOTENSIN SYSTEM; RISK ASSESSMENT; RISK FACTORS;

EID: 33645467638     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005121336     Document Type: Conference Paper

References (39)

1. Frohlich ED: Risk mechanisms in hypertensive heart disease. Hypertension 34: 782-789, 1999
2. Parati G, Pomidossi G, Albini E, Malaspina D, Mancia G: Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 5: 93-98, 1987
3. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, Porcellati C: Circadian blood pressure change and left ventricular hypertrophy in essential hypertension. Circulation 81: 528-536, 1990
4. Rizzoni D, Muiesan ML, Montani G, Zulli R, Calebich S, Agabiti-Rosei E: Relationship between initial cardiovascular structural changes and daytime and nighttime blood pressure monitoring. Am J Hypertens 5: 180-186, 1992
5. de Simone G, Devereux RB, Roman MJ, Alderman MH, Laragh JH: Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension 23: 600-606, 1994
6. de Simone G, Palmieri V, Koren M, Mensah G, Roman MJ, Devereux RB: Prognostic implications of the compensatory nature of left ventricular mass in arterial hypertension. J Hypertens 19: 119-125, 2001
7. Palmieri V, Wachteil K, Gerdts E, Bella JN, Papademetriou V, Tuxen C, Nieminen MS, Dahlof B, de Simone G, Devereux RB: Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: The LIFE study. Am Heart J 141: 784-791, 2001
8. Grassi G, Gianattasio C, Cleroux J, Cuspidi C, Sampieri L, Mancia G: Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension. Hypertension 12: 227-237, 1988
9. Rizzoni D, Agabiti-Rosei E, Castellano M, Beschi M, Montani G, Pizzocolo G, Poiesi C, Rodella A, Agabiti-Rosei E: Antidiuretic hormone and atrial natriuretic peptide during lower body negative or positive pressure in hypertensive patients with and without left ventricular hypertrophy. Clin Exp Hypertens A 14: 717-732, 1992
10. Trimarco B, De Luca N, Ricciardelli B, Rosiello G, Volpe M, Condorelli G, Lembo G, Condorelli M: Cardiac function in systemic hypertension before and after reversal of left ventricular hypertrophy. Am J Cardiol 62: 745-750, 1988
11. Schlaich MP, Schobel HP, Hilgers K, Schmieder RE: Impact of aldosterone on left ventricular structure and function in young normotensive and mildly hypertensive subjects. Am J Cardiol 85: 1199-1206, 2000
12. Woessner JF: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5: 2145-2154, 1991
13. Rizzoni D, Muiesan ML, Porteri E, Salvetti M, Castellano M, Bettoni G, Tiberio G, Giulini SM, Monteduro C, Garavelli G, Agabiti-Rosei E: Relations between cardiac and vascular structure in patients with primary and secondary hypertension. J Am Coll Cardiol 32: 985-992, 1998
14. Rossi GP, Sacchetto A, Pavan E, Palatini P, Graniero GR, Canali C, Pessina AC: Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. Circulation 195: 1471-1478, 1997
15. Verdecchia P, Reboldi G, Schillaci G, Borgioni C, Ciucci A, Telera MP, Santeusanio F, Porcellati C, Brunetti P: Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation 100: 1802-1807, 1999
16. Barouch LA, Berkowitz DE, Harrison RW, O'Donnell CP, Hare JM: Disruption of lectin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation 108: 754-759, 2003
17. Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E, Leonetti G, Magrini F, Zanchetti A: Metabolic syndrome and target organ damage in untreated essential hypertensives. J Hypertens 22: 1991-1998, 2004
18. Post W, Larson M, Myers RH, Galderisi M, Levy D: Heritability of left ventricular mass. Hypertension 30: 1025-1028, 1997
19. Guidelines Committee: 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21: 1011-1053, 2003
20. Devereux RB, Roman MJ: Evaluation of cardiac and vascular structure and function by echocardiography and other non-invasive techniques. In: Hypertension: Pathophysiology, Diagnosis and Management, New York, Raven Press, 1995, pp 1969-1985
21. Sundstrom J, Lind L, Arnlov J, Zethelius B, Andren B, Lithell HO: Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men. Circulation 103: 2346-2351, 2001
22. Okin P, Roman MJ, Lee ET, Galloway JM, Howard B, Devereux RB: Combined echocardiographic left ventricular hypertrophy and electrocardiographic ST depression improve prediction of mortality in American Indians. The Strong Heart Study. Hypertension 43: 769-774, 2004
23. de Simone G, Muiesan ML, Ganau A, Longhini C, Verdecchia P, Palmieri V, Agabiti-Rosei E, Mancia G: Reliability and limitations of measurement of echocardiographic measurement of left ventricular mass for risk stratification and follow-up in single patients: The RES trial. Working Group on Heart and Hypertension of the Italian Society of Hypertension. Reliability of M-mode Echocardiographic Studies. J Hypertens 17: 1960-1964, 1999
24. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH: Patterns of left ventricular hypertrophy and geometric remodeling in arterial hypertension. J Am Coll Cardiol 19: 1550-1558, 1992
25. Di Bello V, Pedrinelli R, Giorgi D, Bertini A, Talarico L, Caputo MT, Massimiliano B, Dell'Omo G, Paterni M, Giusti C: Ultrasonic videodensitometric analysis of two different models of left ventricular hypertrophy: Athlete's heart and hypertension. Hypertension 29: 937-944, 1997
26. Ciulla M, Paliotti R, Hess DB, Tjahja E, Campbell SE, Magrini F, Weber KT: Echocardiographic patterns of myocardial fibrosis in hypertensive patients: Endomyocardial biopsy versus ultrasonic tissue characterization. J Am Soc Echocardiogr 10: 657-664, 1997
27. Vakili B, Okin P, Devereux RB: Prognostic implications of left ventricular hypertrophy. Am Heart J 141: 334-341, 2001
28. Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB: Association of carotid atherosclerotic and left ventricular hypertrophy. J Am Coll Cardiol 25: 83-90, 1995
29. Muiesan ML, Pasini G, Salvetti M, Calebich S, Zulli R, Castellano M, Rizzoni D, Bettoni G, Cinelli A, Porteri E, Corsetti V, Agabiti-Rosei E: Cardiac and vascular structural changes: Prevalence and relation to ambulatory blood pressure in a middle-aged general population in Northern Italy. The Vobarno Study. Hypertension 27: 1046-1052, 1996
30. Lucarini AR, Spessot M, Picano E, Marini C, Lattanzi F, Pedrinelli R, Salvetti A: Lack of correlation between cardiac mass and arteriolar structural changes in mild-to-moderate hypertension. J Hypertens 9: 1187-1191, 1991
31. Niteberg A, Anthony I: Epicardial coronary arteries are not adequately sized in hypertensive patients. J Am Coll Cardiol 27: 115-123, 1996
32. Rizzoni D, Palombo C, Porteri E, Muiesan ML, Kozakova M, La Canna G, Nardi M, Guelfi D, Salvetti M, Morizzo C, Vittone F, Rosei EA: Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients. J Hypertens 21: 615-621, 2003
33. Mancia G, Zanchetti A, Agabiti-Rosei E, Benemio G, De Cesaris R, Fogari R, Pessina A, Porcellati C, Rappelli A, Salvetti A, Trimarco B: Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. Circulation 95: 1464-1470, 1997
34. Parati G, Omboni S, Rizzoni D, Agabiti-Rosei E, Mancia G: The smoothness index: A new reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens 16: 1685-1693, 1998
35. Klingbeil A, Schneider M, Martus P, Messerli F, Schmieder R: A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med 115: 41-46, 2003
36. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Dahlof B; Losartan Intervention for Endpoint reduction in hypertension Study Investigations: Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol. The Losartan Intervention For End-point reduction in hypertension. (LIFE) Study. Circulation 108: 684-690, 2003
37. Muiesan ML, Salvetti M, Rizzoni D, Castellano M, Donato F, Agabiti-Rosei E: Association of change in left ventricular mass with prognosis during longterm antihypertensive treatment. J Hypertens 13: 1091-1097, 1995
38. Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris K, Aurup P, Dahlöf B: Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 292: 2350-2356, 2004
39. Muiesan ML, Salvetti M, Monteduro C, Bonzi B, Paini A, Viola S, Poisa P, Rizzoni D, Castellano M, Agabiti-Rosei E: Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension 43: 1-8, 2004